| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/27/2009 | CA2715924A1 Optimisation of expression of parvoviral rep and cap proteins in insect cells |
| 08/27/2009 | CA2715878A1 Methods, surface modified plates and compositions for cell attachment, cultivation and detachment |
| 08/27/2009 | CA2715397A1 Nucleotide sequences and corresponding polypeptides conferring improved nitrogen use efficiency characteristics in plants |
| 08/27/2009 | CA2710181A1 Method for preserving sperm and applications thereof |
| 08/26/2009 | EP2093565A2 Substrates, devices, and methods for cellular assays |
| 08/26/2009 | EP2093294A1 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 08/26/2009 | EP2093293A2 G-Protein coupled receptors |
| 08/26/2009 | EP2093290A1 Thrombin mutant |
| 08/26/2009 | EP2093287A1 Igg-binding peptide |
| 08/26/2009 | EP2093286A1 Multi-chain eukaryotic display vectors and uses thereof |
| 08/26/2009 | EP2093283A1 Means for improving agrobiological traits in a plant by providing a plant cell comprising in its chloroplasts enzymatic activities for converting glycolate into malate |
| 08/26/2009 | EP2093282A1 Bilirubin oxidase mutant having thermal stability |
| 08/26/2009 | EP2093280A1 Cre-master mouse (mouse strain selectively lacking mast cells) |
| 08/26/2009 | EP2093233A1 Novel compositions and methods in cancer |
| 08/26/2009 | EP2092061A2 (r)-hydroxynitrile lyase from brassicaceae |
| 08/26/2009 | EP2092058A1 Cancerous disease modifying antibodies |
| 08/26/2009 | EP2092057A2 Use of bone marrow cells for long term culture of pancreatic islet cells |
| 08/26/2009 | EP2092056A1 Optimized host cells for protein production |
| 08/26/2009 | EP2091587A1 Ventricular assist device capable of implantation of stem cells |
| 08/26/2009 | EP1994143A4 Method and apparatus for maintenance and expansion of hematopoietic stem cells from mononuclear cells |
| 08/26/2009 | EP1963510B1 Grg23 and grg51 genes conferring herbicide resistance |
| 08/26/2009 | EP1716233B1 Regulated stop codon readthrough |
| 08/26/2009 | EP1711530B1 Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
| 08/26/2009 | EP1624885A4 Synthetic peptide analogs of arg-pro-pro-gly-phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4 |
| 08/26/2009 | EP1423428B1 Antibodies that block fgfr3 activation, methods of screening for and uses thereof |
| 08/26/2009 | EP1370194A4 Composition and methods fro the production of biological tissues and tissue constructs |
| 08/26/2009 | EP1299524B1 Human myeloma cell line |
| 08/26/2009 | EP1282636B1 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 08/26/2009 | EP1237915B1 Polynucleotid encoding the rg1 polypeptide |
| 08/26/2009 | EP1200592B1 Mammalian cytokines; related reagents |
| 08/26/2009 | EP1066324B1 Novel mammalian g-protein coupled receptors having extracellular leucine rich repeat regions |
| 08/26/2009 | EP1037977B1 EXTENDED cDNAs FOR SECRETED PROTEINS |
| 08/26/2009 | EP1007700B1 Monoclonal antibody against a prion protein and its use for the detection of prions |
| 08/26/2009 | CN101517090A Mitotic progression genes and methods of modulating mitosis |
| 08/26/2009 | CN101517079A Non-replicating paramyxoviridae virus vector |
| 08/26/2009 | CN101517075A Cell death inducer |
| 08/26/2009 | CN101517071A Meganuclease variants cleaving a DNA target sequence from a RAG gene and uses thereof |
| 08/26/2009 | CN101517070A Methods of selecting stem cells and uses thereof |
| 08/26/2009 | CN101517069A A novel population of multipotent cardiac precursor cells derived from human blastocysts derived stem cells |
| 08/26/2009 | CN101517068A Human monoclonal antibodies to activin receptor-like kinase-1 |
| 08/26/2009 | CN101517067A Cell delivery matrices |
| 08/26/2009 | CN101516902A Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia |
| 08/26/2009 | CN101516398A Antagonists of protease activated receptor-1 (PAR1) |
| 08/26/2009 | CN101516385A Treatment of excessive neovascularization |
| 08/26/2009 | CN101516383A Methods and compositions for treating disease |
| 08/26/2009 | CN101516180A Early-maturing transformed plant |
| 08/26/2009 | CN101514342A Rice cytoplasmic male sterile genes and application thereof |
| 08/26/2009 | CN101514340A Sequence and application of a promoter of a human autophagic gene beclin 1 |
| 08/26/2009 | CN101514333A Immunologic tolerance dendritic cell, preparation method thereof and special culture medium |
| 08/26/2009 | CN101514231A Fusion protein for resisting formation of thrombus targetedly and preparation method and application thereof |
| 08/26/2009 | CN101514230A Monoclone antibody of ARD1 and application thereof |
| 08/26/2009 | CN100532581C Method and apparatus for decarburization of molten steel |
| 08/26/2009 | CN100532561C New glucoamylase and nucleic acid sequence coding same |
| 08/26/2009 | CN100532560C High specific activity xylanase expression vector |
| 08/26/2009 | CN100532559C Virus envelope vector for gene transfer |
| 08/26/2009 | CN100532558C Optimizing glycan processing in plants |
| 08/26/2009 | CN100532554C Plant anther specific promoter and its application |
| 08/26/2009 | CN100532547C Polyploid breeding method for inducing heterogenous tripoid scallop by physical means |
| 08/26/2009 | CN100532546C Subtilases and subtilase variants having altered immunogenicity |
| 08/26/2009 | CN100532544C Retrovirus encapsulated cell line and liver cell targeted introduction method |
| 08/26/2009 | CN100532543C Culture method of external tissue and its porous carrier |
| 08/26/2009 | CN100531802C Pseudo-type retrovirus vector containing membrane protein having hemagglutinin activity |
| 08/26/2009 | CN100531796C FGFR agonists |
| 08/26/2009 | CN100531553C Method for manufacturing artificial seed |
| 08/25/2009 | US7579531 Rice Cultivar L-206 |
| 08/25/2009 | US7579515 Use of the present invention will enhance proper timing; if the switch increases ovulation >2.4-fold, oocyte production can be achieved even more efficiently, creating major benefits for the transgenic/cloning industry |
| 08/25/2009 | US7579452 immunogenic composition comprising a polynucleotide encoding a nonfunctional mutant Brother of Regulator of Imprinted Sites (BORIS) protein; vaccine against cancer; biodrug delivery of specific nucleic acid |
| 08/25/2009 | US7579447 Antibodies against LLG polypeptides of the triacylglycerol lipase family |
| 08/25/2009 | US7579439 Modulation of IL-2- and IL-15-mediated T cell responses |
| 08/25/2009 | US7579329 P450RAI-2 (P450 cytochrome 26B), encoding nucleic acid molecules and methods and uses thereof |
| 08/25/2009 | US7579327 Isolated polynucleotide sequences; controlling neovasculization; cell growth regulators |
| 08/25/2009 | US7579314 Use of RGD-enriched gelatine-like proteins for inhibition of cancer metastasis |
| 08/25/2009 | US7579189 Aligned scaffolds for improved myocardial regeneration |
| 08/25/2009 | US7579188 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 08/25/2009 | US7579187 Anti-A33 antibody |
| 08/25/2009 | US7579186 Human monoclonal antibody against TGF-β type II receptor and medicinal use thereof |
| 08/25/2009 | US7579179 Activated gaseous oxygen generated by a microwave source, and stream is directed at the surface of polystyrene substrate surface in a controlled fashion such that surface posesses superior adhesion for cells than untreated surface |
| 08/25/2009 | US7579170 Method for preparing monoclonal antibodies capable of activating effector cells expressing FCγRIII |
| 08/25/2009 | US7579168 Human Dickkopf-related nucleic acid molecules |
| 08/25/2009 | US7579150 Mobile RNA acts as a signal to regulate plant growth and development |
| 08/25/2009 | US7579142 Methods for purification of bacterial cells and components |
| 08/25/2009 | US7579141 Method of in vitro diagnosis which discriminates between exposure of a subject to Mycobacterium tuberculosis and vaccination with Bacille Calmette Guerin strain of Mycobacterium bovis, method comprising testing for presence of CD4 T lymphocytes that respond to MTBN4 |
| 08/25/2009 | CA2636876A1 Methods and kits for expanding hematopoietic stem cells |
| 08/25/2009 | CA2385302C Receptor proteins specifically recognizing bacterial dna |
| 08/25/2009 | CA2365276C Method for producing polyhydroxyalkanoates in recombinant organisms |
| 08/25/2009 | CA2088889C Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy |
| 08/22/2009 | CA2619029A1 New cell technologies |
| 08/20/2009 | WO2009102989A1 Low shear pumps for use with bioreactors |
| 08/20/2009 | WO2009102983A2 Efficient induction of pluripotent stem cells using small molecule compounds |
| 08/20/2009 | WO2009102755A1 Enzyme with microbial lysis activity from trichoderma reesei |
| 08/20/2009 | WO2009102697A2 Methods of obtaining antigen-specific t cell populations |
| 08/20/2009 | WO2009102466A1 Well-based flow system for cell culture |
| 08/20/2009 | WO2009102452A2 Compositions and methods for implantation of adipose tissue and adipose tissue products |
| 08/20/2009 | WO2009101968A1 Anti-adam-15 antibodies and utilization of the same |
| 08/20/2009 | WO2009101737A1 Protein expression vector tagged with peptide having methionine residue |
| 08/20/2009 | WO2009101407A2 Improved reprogramming of mammalian cells, and the cells obtained |
| 08/20/2009 | WO2009101228A1 Co-continuous hybrid structure for the regeneration of bone defects |
| 08/20/2009 | WO2009101214A1 Reconstructed cornea and mucous membrane |
| 08/20/2009 | WO2009101207A1 Cd4+ t-cells with cytolytic properties |
| 08/20/2009 | WO2009101181A2 Plasma membrane biomarkers preferentially expressed in pancreatic beta cells useful in imaging or targeting beta cells |